Dear readers,
Yesterday we argued that the Comcast unbundling and the Mobileye acquisition shared a common logic: complexity is being penalized, focus is being rewarded, and capital is following earnings rather than narratives. Today, as the calendar turns to June 30th and Wall Street closes the books on the first half of 2026, that thesis arrives with a full supporting cast. The S&P 500 and the Nasdaq posted their strongest second quarter since 2020 — and yet the most interesting action has been happening not at the index level but in the rotation quietly reshaping what the second half looks like.
The H2 Playbook: Pricing Power Over Promise
In an environment where richly valued future bets are facing increasing scrutiny, investors are gravitating toward established names in consumer staples and enterprise software — businesses that generate cash in the present rather than projecting it into a distant future.
Coca-Cola is the clearest illustration of the type. The beverage giant reported Q1 2026 revenue of $12.50 billion, up 12% year-over-year, with organic revenues rising 10% — driven by an 8% increase in concentrate sales and a 2% improvement in price/mix. A dividend yield of 2.6% provides additional ballast. This is not a growth story in the Silicon Valley sense; it is something more durable: a company that charges more for its products, collects the difference, and returns it to shareholders.
The same logic is driving a rotation within tech — away from hardware speculation and toward cash-generating infrastructure and software franchises. Cisco reported third-quarter revenue of $15.8 billion, up 12%, with GAAP earnings per share of $0.85, a 37% increase. Web-hosting specialist GoDaddy, rarely mentioned alongside the Magnificent Seven, posted revenue of $1.27 billion, up 6.1% year-over-year, at an operating margin of 24.5%. The message for investors is consistent: the premium is shifting from revenue potential to demonstrated profitability and capital returns.
German Inflation Eases; SAP Reshuffles
European investors are getting a modest tailwind from the price front. Germany’s CPI stood at 2.6% year-over-year in May 2026, down from 2.9% in April, and state-level data released on Monday points to a further deceleration in June, with the national reading likely settling around 2.4%. The HICP edged down to 2.7% from 2.9% in April. A key driver has been easing energy costs: following diplomatic progress in the Middle East and ongoing U.S.-Iran talks over the Strait of Hormuz, WTI crude has moved toward $70 per barrel and Brent toward $73.
Against that brightening macro backdrop, the domestic corporate picture at SAP is rather more turbulent. CEO Christian Klein has announced a restructuring of the executive board, explicitly oriented around the company’s artificial intelligence strategy. Reorganizing leadership in the middle of a high-stakes technology pivot is a signal of how much internal pressure there is to translate SAP’s AI ambitions into operational results. The upcoming quarterly report will be the first real test of whether the new structure accelerates execution or introduces friction at precisely the wrong moment.
Should investors sell immediately? Or is it worth buying Coca-Cola?
M&A: Healthcare Writes the Biggest Checks
High interest rates have not cooled the appetite for strategic acquisitions. Global M&A volume is tracking toward approximately $5.3 trillion for the year, which would make 2026 the second-strongest year on record. The deals driving that number are not financial engineering exercises — they are strategically motivated purchases of specific capabilities, made by companies with the balance sheets to act decisively.
The latest example: Merck KGaA announced it will acquire U.S. biotech firm Bio-Techne for $11.3 billion, with the transaction expected to close by late 2026 or early 2027 and cost synergies of roughly €140 million to be fully realized within three years of closing. The target’s expertise in diagnostics and antibody engineering tells you exactly what the acquirer is buying — not revenue, but scientific capability that would take years to build organically. For investors holding quality mid-cap names in healthcare or enterprise software, the M&A environment currently offers a meaningful premium on top of fundamental value.
Hardware Risk: One Raid, Eight Percent
The distance between AI hardware enthusiasm and AI hardware reality was illustrated sharply this week when Taiwanese authorities raided Super Micro Computer’s offices as part of a widening investigation into the alleged smuggling of Nvidia chips to China. SMCI shares fell 8% on the news. Geopolitical and regulatory exposure, long dismissed as theoretical in the semiconductor supply chain, is now arriving as a concrete line item in portfolio risk.
Capital looking for semiconductor exposure without that overhang has a compelling alternative. JPMorgan raised its price target on Broadcom to $580 — naming it a top pick for the second half — against a recent trading price near $396, implying roughly 46% upside. The fundamental case is straightforward: Broadcom reported revenue of $22.19 billion, up 48% year-over-year, supported by a rapidly growing AI order backlog. The company is converting infrastructure demand into real profits without the geopolitical exposure that has made some of its hardware peers difficult to own.
What the Second Half Requires
With Q2 earnings season set to accelerate from mid-July onward, the market’s current valuation levels demand consistent delivery. The indices are near record highs; the margin for disappointment is narrow. In the near term, traders will be watching the JOLTS report and consumer confidence data closely — not as abstract economic indicators, but as evidence that the labor market and household spending can continue to underpin the corporate earnings growth that justifies where prices are.
The rotation we have been tracking for weeks — from narrative to numbers, from promise to proof — is not a prediction about what might happen in the second half. It is a description of what is already happening. The companies that can demonstrate pricing power, defend margins, and generate cash without relying on geopolitical goodwill are the ones drawing capital. The rest are on notice.
Best regards,
The StocksToday.com Editorial
Ad
Coca-Cola Stock: Buy or Sell?! New Coca-Cola Analysis from June 30 delivers the answer:
The latest Coca-Cola figures speak for themselves: Urgent action needed for Coca-Cola investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from June 30.
Coca-Cola: Buy or sell? Read more here...











